Drawing for OSLER

USPTO serial 79424192

OSLER

Reviewed by CopyMark Law Group

Status 681
Filing date
Status date
Registration date
—
Examiner
BLAZICH, JOAN MICHELE
Law office
PUBLICATION AND ISSUE SECTION

What this means

This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.

Need help with OSLER?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Eric Lamb

Eric Lamb FBT Gibbons LLP111 Monument Circle, Suite 4500Indianapolis, IN 46204United States

Goods and services

ClassDescriptionStatusFirst use
001Assays and reagents for scientific or clinical research purposes; in vitro diagnostic reagents for scientific or clinical research purposes; chemical substances, chemical compositions and chemical preparations, namely, chemical reagents for diagnostic testing for scientific or clinical research purposes; diagnostic testing materials, namely, diagnostic assays and reagents for scientific or clinical research purposes; diagnostic preparations, substances, agents, reagents and assays for scientific or clinical research purposes, other than for medical use; diagnostic testing preparations, substances, agents, reagents and assays for scientific or clinical research purposes, other than for medical use, namely, for the testing of blood, body fluids, blood derivatives and body fluid derivatives; diagnostic testing preparations, substances, agents, reagents, assays scientific or clinical research purposes, other than for medical use, namely, for detecting pathogens and biomarkers in whole blood, blood plasma, blood serum, blood cell preparations, cerebrospinal fluid, saliva, mucus, sputum, phlegm, urine, and sweat; diagnostic reagents for in vitro use in haematology, biochemistry, clinical chemistry and microbiology, none being for medical or veterinary use; diagnostic kits comprising sets of reagents for in vitro testing of blood, body fluids, blood derivatives and body fluid derivatives for scientific or clinical research purposes; reagents for conducting electrochemical assays, none being for medical or veterinary use; reagents for conducting enzyme-linked immunosorbent assays, none being for medical or veterinary useACTIVE—
005Diagnostic assays and reagents for medical or veterinary purposes; in vitro diagnostic reagents for medical or veterinary purposes; chemical substances, chemical compositions and chemical preparations, namely, diagnostic assays and reagents for diagnostic testing for medical or veterinary purposes; diagnostic testing materials, namely, diagnostic reagents for medical or veterinary purposes; diagnostic preparations, substances, agents, reagents and assays, for medical or veterinary purposes; diagnostic testing preparations, substances, agents, reagents and assays for medical or veterinary use, namely, for the testing of blood, body fluids, blood derivatives and body fluid derivatives; diagnostic testing preparations, substances, agents, reagents and assays for medical or veterinary use, namely, for detecting pathogens and biomarkers in whole blood, blood plasma, blood serum, blood cell preparations, cerebrospinal fluid, saliva, mucus, sputum, phlegm, urine, and sweat; diagnostic reagents for in vitro use in haematology, biochemistry, clinical chemistry and microbiology for medical or veterinary purposes; diagnostic kits comprising sets of reagents for in vitro testing of blood, body fluids, blood derivatives and body fluid derivatives for medical or veterinary purposes; reagents for conducting electrochemical assays for medical or veterinary purposes; reagents for conducting enzyme-linked immunosorbent assays for medical or veterinary purposesACTIVE—
009Scientific and clinical research apparatus and instruments, namely, analysers and cartridges for laboratory use for haematology, biochemistry, clinical chemistry and microbiology testing; laboratory apparatus and instruments, namely, analysers and cartridges for laboratory use for testing chemical, biological and environmental samples for scientific or clinical research purposes; laboratory apparatus and instruments, namely, diagnostic devices for the analysis of blood, body fluids, blood derivatives and body fluid derivatives for scientific or clinical research purposes; laboratory apparatus and instruments, namely, analysers and cartridges for laboratory use for testing whole blood, blood plasma, blood serum, blood cell preparations, cerebrospinal fluid, saliva, mucus, sputum, phlegm, urine, and sweat for scientific or clinical research purposes; laboratory apparatus and instruments, namely, analysers and cartridges for laboratory use for collecting, storing, processing, testing, analysing and monitoring liquid samples and for reporting in relation to the same; scientific and clinical research apparatus and instruments, namely, devices for collecting, storing, processing, transferring, testing, analysing and monitoring liquid samples of blood, body fluids, blood derivatives and body fluid derivatives and for reporting in relation to the same; scientific and clinical research apparatus and instruments, namely, devices for collecting, storing, processing, transferring, testing, analysing and monitoring liquid samples of whole blood, blood plasma, blood serum, blood cell preparations, cerebrospinal fluid, saliva, mucus, sputum, phlegm, urine, and sweat, and for reporting in relation to the same; scientific and clinical research apparatus and instruments, namely, diagnostic devices for detecting pathogens and biomarkers in liquid samples, blood, body fluids, blood derivatives and body fluid derivatives and for reporting in relation to the same; diagnostic testing apparatus and instruments for the detection and measurement of clinical biomarkers in blood and bodily fluids for scientific or clinical research use; blood testing apparatus for scientific or clinical research purposes; apparatus for blood analysis for scientific or clinical research purposes; monitoring, measuring, signalling and control apparatus and instruments, namely, electronic signal measuring instruments for use in electrochemical analysis, potentiostats, galvanostats and impedance analysers; computer apparatus and instruments, namely, computer hardware and peripheral apparatus for clinical research or scientific purposes; downloadable software for use in the field of analytics and diagnostics, namely, for operating analytical and diagnostic devices being bodily fluid testing apparatus for clinical research purposes and for scientific, veterinary, and medical purposes; downloadable software for operating analytical and diagnostic apparatus, instruments and devices being bodily fluid testing apparatus; downloadable computer software for operating analytical and diagnostic devices being bodily fluid testing apparatus; downloadable computer software for analysing data obtained from blood, body fluids, blood derivatives and body fluid derivatives; downloadable computer application software for management of patient data, healthcare workflow and connectivity between patients and healthcare providers; computer hardware and downloadable software for data capture, collection, recording, processing, transmission, reproduction, storage and communications; structural parts and fittings for all the aforementioned goodsACTIVE—
010Medical and veterinary apparatus and instruments, namely, analysers and cartridges for haematology, biochemistry, clinical chemistry and microbiology testing; medical and veterinary diagnostic instruments for the analysis of blood, body fluids, blood derivatives and body fluid derivatives; medical and veterinary kits comprised of diagnostic cartridges and diagnostic reagents for medical purposes for testing blood, body fluids, blood derivatives and body fluid derivatives; medical and veterinary apparatus and instruments for diagnostic use in analysing whole blood, blood plasma, blood serum, blood cell preparations, cerebrospinal fluid, saliva, mucus, sputum, phlegm, urine, and sweat and for reporting in relation to the same; medical and veterinary apparatus and instruments, namely, devices for collecting, storing, processing, transferring, testing, analysing and monitoring liquid samples of blood, body fluids, blood derivatives and body fluid derivatives, and for reporting in relation to the same; medical and veterinary apparatus and instruments, namely, devices for collecting, storing, processing, transferring, testing, analysing and monitoring liquid samples of whole blood, blood plasma, blood serum, blood cell preparations, cerebrospinal fluid, saliva, mucus, sputum, phlegm, urine, and sweat, and for reporting in relation to the same; medical and veterinary diagnostic apparatus and instruments, namely, diagnostic devices for detecting pathogens and biomarkers in blood, body fluids, blood derivatives and body fluid derivatives, and for reporting in relation to the same; medical and veterinary diagnostic apparatus and instruments, namely, analysers and cartridges for use in diagnosing and monitoring acute and chronic diseases, infectious diseases, hereditary diseases, dietary and metabolic deficiency disorders, and physiological disorders; diagnostic testing apparatus and instruments for the detection and measurement of clinical biomarkers for medical or veterinary use; blood testing apparatus for medical or veterinary purposes; apparatus for blood analysis for medical or veterinary purposes; sample preparation devices for medical or veterinary diagnostic use; electrochemical biosensors for the determination of concentrations of target analytes in body fluids, for medical or veterinary purposes; electronic measuring instruments for medical or veterinary use for the analysis of samples of blood, body fluids, blood derivatives and body fluid derivatives; medical apparatus and instruments, namely, wearable devices with sensors for monitoring patient vital signs, blood and sweat properties and physical movement; structural parts and fittings for all the aforementioned goodsACTIVE—
042Software as a service (SaaS) featuring software and platform as a service (PaaS) services featuring software platforms, both for medical and veterinary data analysis in the field of analytics and diagnostics; providing temporary use of non-downloadable computer software for operating analytical and diagnostic apparatus, instruments and devices being bodily fluid testing apparatus; providing temporary use of non-downloadable computer software for data capture, collection, recording, processing, transmission, reproduction, storage and communications; software as a service (SaaS) services featuring software for analysing data obtained from blood, body fluids, blood derivatives and body fluid derivatives; providing online non-downloadable computer software for the management of patient data, healthcare workflow and connectivity between patients and healthcare providers; consultancy, advisory and information services relating to or connected with all the aforementioned servicesACTIVE—
044Medical services; medical diagnostic services; medical diagnostic testing services, medical analysis services for diagnostic, treatment and patient risk assessment purposes, medical monitoring services, and medical reporting services; medical testing, screening and analysis services relating to the diagnosis and treatment of disease, namely, acute and chronic diseases, infectious diseases, hereditary diseases, dietary disorders, metabolic deficiency disorders, and physiological disorders; consultancy, advisory and information services relating to or connected with all the aforementioned servicesACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Nov 5, 2026OPNXNOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB—
Nov 4, 2026NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Oct 21, 2026OPNSNOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB—
Oct 21, 2026OPNRNOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB—
Oct 13, 2026CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Oct 9, 2026GNENNOTIFICATION OF EXAMINERS AMENDMENT E-MAILED—
Oct 9, 2026XAECEXAMINER'S AMENDMENT ENTERED—
Oct 9, 2026GNEAEXAMINERS AMENDMENT E-MAILED—
Oct 9, 2026CNEAEXAMINERS AMENDMENT -WRITTEN—
Apr 15, 2026GNFNNOTIFICATION OF FINAL REFUSAL EMAILED—
Apr 15, 2026GNFRFINAL REFUSAL E-MAILEDA final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon.
Apr 15, 2026CNFRFINAL REFUSAL WRITTENA final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon.
Mar 20, 2026TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Mar 20, 2026CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Mar 20, 2026TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Mar 18, 2026ECDRTEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS—
Mar 18, 2026ARAAATTORNEY/DOM.REP.REVOKED AND/OR APPOINTEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Mar 18, 2026REAPTEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED—
Mar 18, 2026CHANAPPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED—
Mar 18, 2026COARTEAS CHANGE OF OWNER ADDRESS RECEIVED—
Oct 10, 2025RFNTREFUSAL PROCESSED BY IB—
Sep 23, 2025RFCSNON-FINAL ACTION MAILED - REFUSAL SENT TO IB—
Sep 23, 2025RFRRREFUSAL PROCESSED BY MPU—
Aug 12, 2025RFCRNON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW—
Aug 11, 2025CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Aug 7, 2025DOCKASSIGNED TO EXAMINER—
May 26, 2025MAFRAPPLICATION FILING RECEIPT MAILED—
May 26, 2025NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
May 22, 2025REPRSN ASSIGNED FOR SECT 66A APPL FROM IB—

Frequently asked questions

Related guidance